Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Patti, C.
1754  Ergebnisse:
Personensuche X
?
1

Radioimmunotherapy versus autologous hematopoietic stem cel..:

Ladetto, M. ; Tavarozzi, R. ; Zanni, M....
Annals of Oncology.  35 (2024)  1 - p. 118-129 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in r..:

McDonald, A. ; Verburgh, E. ; Gotti, M....
Hematological Oncology.  41 (2023)  S2 - p. 575-577 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Baseline‐PET derived metrics are the most relevant factors ..:

Zaucha, J. M. ; Picardi, M. ; Kurlapski, M....
Hematological Oncology.  41 (2023)  S2 - p. 350-351 , 2023
Link: https://doi.org/10.1002/..
 
?
4

FRONTLINE INTENSIFIED ABVD DEMONSTRATES SUPERIOR EFFICACY T..:

Pinto, A. ; Corazzelli, G. ; Evangelista, A....
Hematological Oncology.  41 (2023)  S2 - p. 31-33 , 2023
Link: https://doi.org/10.1002/..
 
?
5

P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (..:

Strati, P. ; Coleman, M. ; Stevens, D....
HemaSphere.  6 (2022)  - p. 1019-1020 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P664: GRADING QUALITY OF EVIDENCE AND STRENGTH OF RECOMMEND..:

Molica, S. ; Patti, C. ; Sportoletti, P....
HemaSphere.  6 (2022)  - p. 562-563 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOI..:

Ladetto, M. ; Tavarozzi, R. ; Evangelista, A....
HemaSphere.  6 (2022)  - p. 1032-1033 , 2022
Link: https://doi.org/10.1097/..
 
?
8

ROMIDEPSIN‐CHOEP PLUS UP‐FRONT STEM‐CELL TRANSPLANTATION IN..:

Chiappella, A. ; Carniti, C. ; Re, A....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
9

BRENTUXIMAB VEDOTIN CONSOLIDATION AFTER AUTOLOGOUS STEM CEL..:

Massaro, F. ; Pavone, V. ; Stefani, P. M....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
10

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILUR..:

Gallamini, A ; Rambaldi, A ; Patti, C...
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
11

A NON‐INTERVENTIONAL STUDY OF OBINUTUZUMAB IN PATIENTS WITH..:

., A ; . Zinzani, P. L ; . Arcaini, L...
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
12

FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN S..:

Ferrero, S. ; Ladetto, M. ; Beldjord, K....
Hematological Oncology.  37 (2019)  S2 - p. 224-225 , 2019
Link: https://doi.org/10.1002/..
 
?
13

IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2‐POSITIVE DIFF..:

Morschhauser, F. ; Flinn, I.W. ; Gasiorowski, R....
Hematological Oncology.  37 (2019)  S2 - p. 135-137 , 2019
Link: https://doi.org/10.1002/..
 
?
14

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HOD..:

Gallamini, A. ; Rossi, A. ; Patti, C....
Hematological Oncology.  37 (2019)  S2 - p. 147-148 , 2019
Link: https://doi.org/10.1002/..
 
?
15

Palaeogeographical evolution of the Egadi Islands (western ..:

Lo Presti, V. ; Antonioli, F. ; Palombo, M.R....
Earth-Science Reviews.  194 (2019)  - p. 160-181 , 2019
Link: https://doi.org/10.1016/..
 
1-15